These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 26730133)

  • 21. Swarna Bindu Prashana-an Ancient Approach to Improve the Infant's Immunity.
    Nelaturi P; Nagarajan P; Sabapathy SK; Sambandam R
    Biol Trace Elem Res; 2021 Jun; 199(6):2145-2148. PubMed ID: 32856248
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Performance Status Assessment by Using ECOG (Eastern Cooperative Oncology Group) Score for Cancer Patients by Oncology Healthcare Professionals.
    Azam F; Latif MF; Farooq A; Tirmazy SH; AlShahrani S; Bashir S; Bukhari N
    Case Rep Oncol; 2019; 12(3):728-736. PubMed ID: 31616281
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Wound healing efficacy of Jatyadi Taila: in vivo evaluation in rat using excision wound model.
    Shailajan S; Menon S; Pednekar S; Singh A
    J Ethnopharmacol; 2011 Oct; 138(1):99-104. PubMed ID: 21907784
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of Nasya and Matra Basti with Narayana Taila on anovulatory factor.
    Donga KR; Donga SB; Dei LP
    Ayu; 2013 Jan; 34(1):81-5. PubMed ID: 24049410
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic Evaluation of Neurological Assessment of the Neuro-Oncology Scale in Glioblastoma Patients.
    Lee J; Park SH; Kim YZ
    Brain Tumor Res Treat; 2018 Apr; 6(1):22-30. PubMed ID: 29644808
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development of Ayurveda - Tradition to trend.
    Mukherjee PK; Harwansh RK; Bahadur S; Banerjee S; Kar A; Chanda J; Biswas S; Ahmmed SM; Katiyar CK
    J Ethnopharmacol; 2017 Feb; 197():10-24. PubMed ID: 27633405
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Standardisation of the ayurvedic medicine pindataila.
    Hepsibah PT; Rosamma MP; Prasad NB; Kumar PS
    Anc Sci Life; 1996 Jan; 15(3):222-5. PubMed ID: 22556746
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Karnofsky and ECOG performance status scoring in lung cancer: a prospective, longitudinal study of 536 patients from a single institution.
    Buccheri G; Ferrigno D; Tamburini M
    Eur J Cancer; 1996 Jun; 32A(7):1135-41. PubMed ID: 8758243
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The G8 screening tool enhances prognostic value to ECOG performance status in elderly cancer patients: A retrospective, single institutional study.
    Takahashi M; Takahashi M; Komine K; Yamada H; Kasahara Y; Chikamatsu S; Okita A; Ito S; Ouchi K; Okada Y; Imai H; Saijo K; Shirota H; Takahashi S; Mori T; Shimodaira H; Ishioka C
    PLoS One; 2017; 12(6):e0179694. PubMed ID: 28640844
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Amrita Bindu--a salt-spice-herbal health food supplement for the prevention of nitrosamine induced depletion of antioxidants.
    Shanmugasundaram KR; Ramanujam S; Shanmugasundaram ER
    J Ethnopharmacol; 1994 Apr; 42(2):83-93. PubMed ID: 8072308
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy of Yavakshara Taila Uttarabasti in the management of fallopian tube blockage.
    Baria HP; Donga SB; Dei L
    Ayu; 2015; 36(1):29-33. PubMed ID: 26730135
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Analysis of prognostic factors and applicability of Kohne's prognostic groups in patients with metastatic colorectal cancer treated with first-line irinotecan or oxaliplatin-based chemotherapy.
    Díaz R; Aparicio J; Gironés R; Molina J; Palomar L; Segura A; Montalar J
    Clin Colorectal Cancer; 2005 Sep; 5(3):197-202. PubMed ID: 16197623
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Patient-Reported Functional Status in Outpatients With Advanced Cancer: Correlation With Physician-Reported Scores and Survival.
    Popovic G; Harhara T; Pope A; Al-Awamer A; Banerjee S; Bryson J; Mak E; Lau J; Hannon B; Swami N; Le LW; Zimmermann C
    J Pain Symptom Manage; 2018 Jun; 55(6):1500-1508. PubMed ID: 29496534
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic value of health-related quality of life in patients with metastatic pancreatic adenocarcinoma: a random forest methodology.
    Diouf M; Filleron T; Pointet AL; Dupont-Gossard AC; Malka D; Artru P; Gauthier M; Lecomte T; Aparicio T; Thirot-Bidault A; Lobry C; Fein F; Dubreuil O; Landi B; Zaanan A; Taieb J; Bonnetain F
    Qual Life Res; 2016 Jul; 25(7):1713-23. PubMed ID: 26615615
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A comparative study of Prameha Roga from the Brihatrayee.
    Baruah D; Gupta OP
    Bull Indian Inst Hist Med Hyderabad; 2002; 32(2):93-107. PubMed ID: 15981374
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Survival Analysis of Advanced HCC Treated with Radioembolization: Comparing Impact of Clinical Performance Status Versus Vascular Invasion/Metastases.
    Ali R; Gabr A; Abouchaleh N; Al Asadi A; Mora RA; Kulik L; Abecassis M; Riaz A; Salem R; Lewandowski RJ
    Cardiovasc Intervent Radiol; 2018 Feb; 41(2):260-269. PubMed ID: 28879621
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Simple prognostic model for patients with advanced cancer based on performance status.
    Jang RW; Caraiscos VB; Swami N; Banerjee S; Mak E; Kaya E; Rodin G; Bryson J; Ridley JZ; Le LW; Zimmermann C
    J Oncol Pract; 2014 Sep; 10(5):e335-41. PubMed ID: 25118208
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparative analysis of comorbidity and performance indices for prediction of oncological outcomes in patients with upper tract urothelial carcinoma who were treated with radical nephroureterectomy.
    Aziz A; Fritsche HM; Gakis G; Kluth LA; Hassan Fa; Engel O; Dahlem R; Otto W; Gierth M; Denzinger S; Schwentner C; Stenzl A; Shariat SF; Fisch M; Burger M; Rink M
    Urol Oncol; 2014 Nov; 32(8):1141-50. PubMed ID: 24856977
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of ECOG/WHO performance status and ASA score as a measure of functional status.
    Young J; Badgery-Parker T; Dobbins T; Jorgensen M; Gibbs P; Faragher I; Jones I; Currow D
    J Pain Symptom Manage; 2015 Feb; 49(2):258-64. PubMed ID: 24996034
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Poor-Performance Status Assessment of Patients with Non-small Cell Lung Cancer Remains Vague and Blurred in the Immunotherapy Era.
    Friedlaender A; Banna GL; Buffoni L; Addeo A
    Curr Oncol Rep; 2019 Nov; 21(12):107. PubMed ID: 31768759
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.